H16.329
Diffuse interstitial keratitis, unspecified eye
Clinical Classification Guidelines
Medical Intelligence & Overview
Diffuse interstitial keratitis is a type of corneal inflammation that affects the middle layer of the cornea, known as the stroma. This condition often involves a diffuse, widespread inflammation across the cornea, leading to discomfort and visual disturbances. The term 'unspecified eye' indicates that the diagnosis does not specify whether the affected eye is the left or right. Although it can affect either eye, the condition requires careful evaluation to determine the extent of inflammation and appropriate management.
Causes & Symptoms
Clinical Causes: Infections, such as syphilis, herpes simplex virus, or tuberculosis Autoimmune diseases, including rheumatoid arthritis and sarcoidosis Trauma to the eye Idiopathic causes, where no specific reason is identified Exposure to certain toxic substances or medications that may provoke immune responses
Key Symptoms: Redness of the eye Pain or discomfort, which may be mild to severe Blurred vision or decreased visual acuity Sensitivity to light (photophobia) Tearing or watery eyes A dull or aching sensation around the eye
Diagnostic & Treatment
Diagnosis Path: Diagnosing diffuse interstitial keratitis involves a detailed eye examination by an ophthalmologist. The doctor may use slit-lamp biomicroscopy to observe the corneal changes closely and assess the extent of inflammation. Additional tests may include corneal scrapings, blood tests to detect infections or autoimmune markers, and imaging studies if necessary. The goal of diagnosis is to rule out other eye conditions with similar symptoms and to identify any underlying systemic disease that may contribute to the keratitis.
Treatment Protocols: Topical corticosteroid eye drops to decrease inflammation Antiviral or antibiotic medications if an infectious cause is identified Systemic antibiotics or corticosteroids for systemic infections or autoimmune conditions Immunomodulatory therapies, in cases linked to autoimmune diseases Artificial tears or lubricating eye drops to soothe the eye Regular follow-up appointments to monitor disease progression and treatment response
Clinical Advice & FAQs
Billing Guidance
Is H16.329 a billable ICD-10 code?
Yes, H16.329 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H16.329?
Clinical documentation must specify the nature of Diffuse interstitial keratitis, unspecified eye and any associated comorbidities for accurate reporting.
Cite this Clinical Reference